A phase I and pharmacokinetic study of squalamine, a novel antiangiogenic agent, in patients with advanced cancers.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
Reporting results of cancer treatment
1981 • 7,916 citations
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 • 2,774 citations
Clinical Applications of Research on Angiogenesis
1995 • 2,300 citations
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
1997 • 1,705 citations
Squalamine: an aminosterol antibiotic from the shark.
1993 • 410 citations
Endothelial-cell proliferation in experimental tumours
1982 • 236 citations
Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature.
1998 • 165 citations
Squalamine, a novel cationic steroid, specifically inhibits the brush-border Na+/H+exchanger isoform NHE3
1999 • 130 citations
Structure of the novel steroidal antibiotic squalamine determined by two-dimensional NMR spectroscopy
1993 • 75 citations
Potentiation of platinum antitumor effects in human lung tumor xenografts by the angiogenesis inhibitor squalamine: effects on tumor neovascularization.
1999 • 70 citations
Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma.
1998 • 55 citations
New approaches in preclinical and clinical pharmacokinetics.
1993 • 11 citations